"Is this the first meaningfully + neuroprotectant trial? APRIL showed lower mortality, infarct vol, better outcomes with ApToll infusion+EVT #isc23 ⁦@HenryFordNeuro⁩ ⁦@OwaisAlsrouji⁩ ⁦@WBrinjikji⁩ ⁦@stephanamayer⁩ ⁦@GhadaMohamedMD⁩ ⁦@aboulnourh⁩"